Connection is the product, materials are a liability, and fringe therapies are going clinical.
Protocole launches with $6M in funding
The company is building a clinical-grade peptide platform, connecting users to licensed clinicians, regulated pharmacies, and formalized treatment.
- Protocole offers personalized protocols across longevity, performance, and metabolic health.
- Reframing peptides as standard care, Protocole is creating infrastructure for responsible use.
As the category shifts toward regulated channels, platforms that combine quality control are emerging to support broader adoption.
The connection economy takes shape
New platforms are reimagining nightlife — elevating arts and cultural events to crowd out screentime. Capital is following the shift.
- Posh closed a $37M Series B for its Netflix-like social event platform.
- Hollywood mogul Ari Emanuel raised ~$3B to launch live events holding company MARI.
- Mark Cuban backed nightlife experience company Burwoodland.
Apps like Partiful and emerging players like Rumor are building social layers around events — from pre-event coordination to post-event interactions.
An antidote to the digital era, IRL is influencing new environments and tech-enabled hangouts to take shape.
Activewear faces scrutiny
The Texas attorney general is investigating lululemon over “forever chemicals” in its fabric.
- Safety concerns are tied to potential exposure to PFAS, a group of synthetic compounds linked to cancer, infertility, and hormone disruption.
- Said materials and chemical treatments exist across performance apparel brands to deliver durability, stretch, and water resistance.
- Toxic-free and ingredient-aware lifestyles are becoming more popular, putting the tradeoff into focus.
As expectations shift toward transparency and safer materials, natural materials that retain function will become a differentiator for challengers and a liability for incumbents.
